|
Volumn 8, Issue 5, 2007, Pages 259-
|
We have a problem: Why have ALS trials been negative?
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIOXIDANT;
APOPTOSIS INHIBITOR;
NEUROTROPHIC FACTOR;
AMYOTROPHIC LATERAL SCLEROSIS;
CEREBROSPINAL FLUID;
CLINICAL RESEARCH;
CLINICAL TRIAL;
DISEASE COURSE;
EARLY DIAGNOSIS;
EDITORIAL;
HUMAN;
HUMAN VERSUS ANIMAL COMPARISON;
MORTALITY;
MOTONEURON;
MOTOR NEURON DISEASE;
MUSCLE WEAKNESS;
NONHUMAN;
NUTRITIONAL STATUS;
NUTRITIONAL SUPPORT;
PRIORITY JOURNAL;
RESPIRATORY FAILURE;
SURVIVAL RATE;
THERAPY DELAY;
AMYOTROPHIC LATERAL SCLEROSIS;
CLINICAL TRIALS AS TOPIC;
EVALUATION STUDIES AS TOPIC;
HUMANS;
OUTCOME ASSESSMENT (HEALTH CARE);
|
EID: 35148888208
PISSN: 17482968
EISSN: 1471180X
Source Type: Journal
DOI: 10.1080/17482960701649887 Document Type: Editorial |
Times cited : (8)
|
References (0)
|